Prevalence of cardiometabolic co-morbidities in patients with vs persons without chronic hepatitis B: The FitLiver cohort study

Table 3 Physical activity of patients with chronic hepatitis B and a comparison group from the general population matched on age, sex, body mass index, and country-of-birth

	All participants	Chronic hepatitis B	Comparison group	P value
Participants, n	147	98	49
VO2max, mean (± SD), mL/kg/minute	28.0 (± 7.7)	26.9 (± 7.5)	30.2 (± 7.6)	< 0.05
Self-assessed physical activity
MVPA, median (IQR), minute/week	120 (353)	68 (262)	188 (406)	< 0.05
Walking activity, mean (± SD), minute/week	243 (± 548)	290 (± 538)	180 (± 364)	0.10
Sitting time, mean (± SD), minute/week	2100 (± 2047)	1680 (± 1470)	2625 (± 1680)	< 0.05a
Measured physical activity
MVPA, median (IQR), minute/week	388 (230)	357 (257)	424 (204)	0.23
Walking activity, mean (± SD), minute/week	624 (± 232)	628 (± 248)	615 (± 201)	0.76
Sitting time, mean (± SD), minute/week	3471 (± 981)	3536 (± 992)	3345 (± 957)	0.27
Sedentary time, median (IQR), minute/week	8399 (656)	8449 (735)	8393 (567)	0.65

^aP < 0.05 indicates statistical significance after Bonferroni correction. A P value of < 0.05 is considered to show a trend.

According to normality distribution, data is given in mean (± SD) or median (interquartile range). Quantitative outcome variables were compared using the independent t-test and Mann-Whitney U test according to normality distribution. Fisher’s exact test was used to analyze categorical data. IQR: Interquartile range; MVPA: Moderate-to-vigorous physical activity; VO₂max: Maximal oxygen consumption.